BridgeBio Pharma Inc (FRA:2CL)
€ 60.3 +0.020 (+0.03%) Market Cap: 12.02 Bil Enterprise Value: 13.40 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

BridgeBio Pharma Inc Annual Shareholders Meeting Transcript

Jun 22, 2026 / 06:00PM GMT
Release Date Price: €57.36 (+0.33%)
Operator

Hello, and welcome to the 2026 Annual Meeting of BridgeBio Pharma, Inc. Please note that today's meeting is being recorded.

I will now introduce your host for today's meeting, Dr. Neil Kumar. Sir, please go ahead.

Neil Kumar
BridgeBio Pharma Inc - Chief Executive Officer, Director

Thank you, and good morning, everyone. My name is Neil Kumar, Chief Executive Officer of BridgeBioPharma, Incorporated, and I will be presiding as Chairman of today's meeting.

The meeting is now called to order. Mr. William Solis, Assistant General Counsel of BridgeBio, will serve as Secretary of today's meeting.

It is a pleasure to welcome our stockholders and guests to the Annual Meeting of BridgeBio Pharma. We are conducting this meeting entirely as an interactive webcast. This meeting is being held in accordance with the corporation's amended and restated bylaws and Delaware law.

In our meeting today, we will review the matters described in our notice and proxy statement, a copy of which was mailed or made available on the Internet on or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot